David Johnston
Plus aucun poste en cours
Profil
Le Dr David Johnston est vice-président exécutif chargé du développement clinique mondial chez PPD, Inc. Auparavant, le Dr Johnston était employé en tant que premier vice-président de Laboratory Corp. of America Holdings. Il a également siégé au conseil d'administration de Locus Biosciences, Inc. Il a obtenu son diplôme de premier cycle à l'Université de Caroline du Nord à Greensboro et un doctorat à l'École de médecine de l'UNC.
Anciens postes connus de David Johnston
| Sociétés | Poste | Fin |
|---|---|---|
| PPD, INC. | President | 01/10/2023 |
| THERMO FISHER SCIENTIFIC | Chief Tech/Sci/R&D Officer | - |
Locus Biosciences, Inc.
 Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Director/Board Member | - |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Corporate Officer/Principal | - |
Formation de David Johnston
| The University of North Carolina at Greensboro | Undergraduate Degree |
| UNC School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Health Services |
| THERMO FISHER SCIENTIFIC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Technology Services |
PPD, Inc.
 PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
